Depression is the second most common chronic disease, which is widely expanding in the world. It has been reported that about half of the patients are unaware of their disease or their disease has been diagnosed else.\[[@ref1][@ref2]\] The patients show a combination of states of sadness, loneliness, irritability, absurdity, despair, confusion and shame and sometimes they reveal physical symptoms.\[[@ref1]\] Treatment by drugs or psychotherapeutic methods has been reported unsuccessful in 20% and 35% of patients.\[[@ref3][@ref4]\]

Neuroimmune factors have been suggested to have an important role in depression.\[[@ref5][@ref6]\] The increased levels of the inflammatory markers such as C-reactive protein, interleukin-6 (IL-6) and tumor necrosis factor alpha in depression may be a good evidence for this idea.\[[@ref7][@ref8]\] It has also been shown that antidepressants affect cytokine levels, which the later affect the treatment outcome in depression.\[[@ref9][@ref10]\] The glial cell activation and their response during neuroinflammation has also been shown to have an important role in depression.\[[@ref11]\] It was also shown that antidepressant agents have anti-neuroinflammatory properties as well.\[[@ref11]\] The studies using animal models as well *in vitro* studies on rodent glial cells, have confirmed that different types of antidepressants affect the expression of inflammatory mediators, such as cytokines, microglials and astroglials in the nervous system.\[[@ref11]\]

Ovalbumin sensitization and challenge causes an inflammatory response in the airways and therefore, it has been frequently used as an animal model of asthma.\[[@ref12]\] This model is accompanied with acute inflammatory events including infiltration of inflammatory cells such as eosinophils, mast cells, neutrophils and lymphocytes.\[[@ref13][@ref14]\] In sensitized animals, both CD4+ and CD8+ cells are activated which they then express Th2 cytokines.\[[@ref15]\] The Th2 responses typically lead to an increase in IL-4, IL-5 and IL-13.\[[@ref16]\] It was also shown that that the serum levels of interferon (IFN)-γ was increased in sensitized animals compared with the control.\[[@ref17]\] There is also a close link between peripheral and brain inflammation due to ovalbumin sensitization.\[[@ref18]\]

*Valeriana officinalis* L. (Valerian) is a plant native to different temperate regions of America, Europe and Asia.\[[@ref19]\] Several therapeutic effects including hypnotic, sedative, anxiolytic, anticonvulsant and antidepressant has been suggested for Valerian.\[[@ref20][@ref21][@ref22]\] The rhizomes of Valerian contain several compounds including the essential oil and its sesquiterpenoids (valerenic acid), epoxy iridoid esters (valepotriates, valtrate, didravaltrate), amino acids (arginine, γ-aminobutyric acid \[GABA\], glutamine, tyrosine) and alkaloids.\[[@ref23]\] It has also been reported that the ethanolic and aqueous extracts of valerian root inhibited GABA reuptake.\[[@ref24]\] In traditional medicine, a variety of herbal preparations from this plant has been advised to use for treatment of hypertension, angina, palpitation, asthma, hepatic colic and menstrual cramps.\[[@ref25][@ref26][@ref27][@ref28]\] Antidepressant activity of sesquiterpenes which were fractioned from the roots of Valeriana fauriei Briq, the other genus of Valerianaceae, has also been reported.\[[@ref29]\]

Based on the properties of *V. officinalis L*. which has been reported in traditional medicine and in experimental studies, the present study was designed in order to evaluate the possible effects of hydro-alcoholic extract of *V. officinalis L*. on depression like behavior in ovalbumin sensitized rats.

Materials and Methods {#sec1-1}
=====================

Preparing the hydroalcoholic plant extract {#sec2-1}
------------------------------------------

The plant was identified by the botanists in Ferdowsi University, Mashhad (No: 295-2215-1). To prepare the hydroalcoholic extract, the powdered rhizomes (100 g) of *V. officinalis* were extracted in a Soxhlet extractor with ethanol (70%). The resulting extract was concentrated under reduced pressure. Five grams extract was yielded from 100 g of the powdered rhizomes. The extract was kept at −20°C until being used. The extract was dissolved in saline.\[[@ref30][@ref31][@ref32]\]

Animals and the experimental protocol {#sec2-2}
-------------------------------------

A total of 50 male Wistar rats (8 weeks old and weighted 230 ± 20 g) were kept at 22 ± 2°C and 12 h light/dark cycle at 7:00 am. They were randomly divided to five groups and treated according to the experimental protocol for 32 days. All measurements were performed between 10.00 and 14.00.

Rats in group 1 (control group) received saline instead of both ovalbumin and the extract. The animals in group 2 (sensitized; Sent) were injected by saline instead of the extract. The animals in this group were sensitized based on the protocol. Groups 3 (sensitized -- extract 50; Sent-Ext 50), 4 (sensitized -- Extract 100; Sent-Ext100) and 5 (sensitized -- extract 200; Sent-Ext 200) were treated by 50, 100 and 200 mg/kg of the extract respectively from the day before conducting the sensitization and during the sensitization. The doses were chosen from previous studies.\[[@ref33][@ref34]\]

Sensitization of the animals to ovalbumin was performed using the method described previously.\[[@ref12][@ref35][@ref36]\] Briefly, the rats were sensitized to ovalbumin (Sigma Chemical Ltd., UK) by i.p. injection of 10 mg ovalbumin and 100 mg Al(OH)3 dissolved in 1 ml saline on day 1. At 1 week later they were given 2 mg ovalbumin and 100 mg Al(OH)3 dissolved in 1 ml saline i.p. as a booster dose. From day 14, the sensitized animals were exposed to an aerosol of 4% ovalbumin for 18-19 days, 5 min daily. The aerosol was administered in a closed cylinder, dimensions 19 cm diagonal and 16 cm high and 3 L volume using a nebulizer (Cx3, Omron Healthcare Europe B.V., Netherlands). The animals were placed in the cylinder separately. Control animals were treated similarly but saline was used instead of ovalbumin solution. The study was approved by the ethical committee of Mashhad University of Medical Sciences (NO: AC-34o-1390).

Behavioral procedures {#sec2-3}
---------------------

### Forced swimming test {#sec3-1}

17 day after aerosol administration, the animals were compromised to the test room environment for 1 h before the beginning of the experiment. During the FST, the animals were placed in a glass cylindrical tank with 60 cm height and 38 cm width which was filled with water (24 ± 1°C) to the depth of 40 cm. The water was changed between each animal. In the 1^st^ day (day 17 of aerosol administration), the rats were placed inside the water cylinder for 15 min (pre-test). In the next day (day 18 of aerosol administration), the animals were placed individually inside the water cylinder for 5 min.\[[@ref37]\] The time of floating (immobility) during the FST was recorded for 5 min.\[[@ref38][@ref39]\] Rats were considered immobile when they floated in the water; they only performed movements that enabled them to keep their head above the water. The movements of the animals were recorded by a camera and it was then evaluated by an experimenter who was blind to the animals. After the FST, the rats were dried in a heated cage and then they were returned to their home cages.\[[@ref40][@ref41]\]

### Open-field {#sec3-2}

Open-field test was used for studying the depression-like behaviors of animals.\[[@ref41][@ref42]\] It was done on day 19 of aerosol administration. In the present study, the open-field measurement was done by a wooden apparatus with an area of 100 cm × 100 cm and height of 40 cm. Inside the apparatus was divided to 16 equal squares using a black line. In addition, within the apparatus was divided to two zones called peripheral and central zones.\[[@ref43][@ref44][@ref45]\] All the rats were familiarized with the test environment by being placing in the room for 1-h before beginning the experiment. During the experiment a low-level light was used to reduce anxiety.\[[@ref40]\] Each animal was placed in the central zone and its movement was recorded by a digital camera for 5 min\[[@ref43][@ref44][@ref45]\] and the following criteria were calculated: (1) The crossing number in the central zone, (2) the crossing number in the peripheral zone and (3) rearing counts: The number of vertical movement when the rat stood vertically on its hind paws on the floor and forepaws on the wall.\[[@ref40][@ref41]\] Both behavioral testes were carried out 2 h after aerosol administration.

Statistical analysis {#sec2-4}
--------------------

The data were expressed as mean ± standard error of the mean the two-way ANOVA (factor 1: Treatment; factor 2: Sensitization) was run followed by tukey *post hoc* comparisons test. The criterion for the statistical significance was *P* \< 0.05.

Results {#sec1-2}
=======

The results of the FST showed that the animals in the sensitized group had 102.66 ± 9.99 s immobility times while; the immobility time in the animals of sensitized group was 63.33 ± 7.03 s. Two-way ANOVA test showed that both sensitization and treatment affected the immobility time (*P* \< 0.01 for sensitization and *P* \< 0.05 for treatment). In the Sent-Ext 100 and Sent-Ext 200 groups, the immobility times were 71.57 ± 5.14 and 54.28 ± 7.47 sec, respectively. Tukey *post hoc* analysis showed that they were significantly lower than that of sensitized animals (*P* \< 0.05 and *P* \< 0.01). There were also no significant differences between the Sent-Ext 100 and Sent-Ext 200 groups compared with the control group in immobility times. Treatment of the sensitized rats by 50 mg/kg of the extract didn\'t show significant effects \[[Figure 1](#F1){ref-type="fig"}\].

![Comparison of immobility times in the forced swimming test between five groups. Data are expressed as mean ± standard error of the mean (*n* = 10 in each group). \*\**P* \< 0.01 comparison of sensitized group with control group, +*P* \< 0.05 and ++*P* \< 0.01 comparison of sensitized animals treated by 100 and 200 mg/kg of the extract respectively groups with non treated sensitized group. The two ANOVA followed by Tukey *post hoc* test. The criterion for the statistical significance was *P* \< 0.05](JPBS-6-97-g001){#F1}

The results of the open-field test showed that the number of crossing in the peripheral zone by the animals of sensitized group was 71.83 ± 11.45 while in the control group it was 39.62 ± 3.55. Two-way ANOVA test showed that both sensitization and treatment affected the immobility time (*P* \< 0.01 for sensitization and *P* \< 0.001 for treatment). As shown in [Figure 2](#F2){ref-type="fig"}, the crossing number in the peripheral zone by the animals of Sent-Ext 50, Sent-Ext 100 and Sent-Ext 200 groups were 39 ± 4.4, 32.75 ± 7.59 and 22.25 ± 7.74 respectively. Tukey post hoc analysis showed that they were significantly lower than that in the sensitized group (*P* \< 0.05 and *P* \< 0.01) \[[Figure 2](#F2){ref-type="fig"}\]. There was no significant difference between three doses of the extract.

![Comparison of the number of crossing in the peripheral zone in the open-field test. Data are expressed as mean ± standard error of the mean (*n* = 10 in each group). \*\**P* \< 0.01 comparison of sensitized group with control group, +*P* \< 0.05 and ++*P* \< 0.01 comparison of sensitized animals treated by 50, 100 and 200 mg/kg of the extract respectively, with non-treated sensitized group. The two ANOVA followed by Tukey *post hoc* test. The criterion for the statistical significance was *P* \< 0.05](JPBS-6-97-g002){#F2}

The results also showed that the number of crossing in the central zone by the sensitized and control groups were 3 ± 0.68 and 8.83 ± 0.6 respectively. Two-way ANOVA test showed that both sensitization and treatment affected the immobility time (*P* \< 0.001 for sensitization and *P* \< 0.05 for treatment). The crossing number in the central zone by the animals of Sent-Ext 200 group was 7.33 ± 0.98; it was significantly higher than that of the sensitized group (*P* \< 0.05) \[[Figure 3](#F3){ref-type="fig"}\]. Treatment the sensitized rats by 50 and 100 mg/kg didn\'t show a significant effect on the crossing number in the central zone. There were no significant differences between groups in rearing number \[[Figure 4](#F4){ref-type="fig"}\].

![Comparison of the number of crossing in the central zone in the open-field test. Data are expressed as mean ± standard error of the mean (*n* = 10 in each group). \*\*\**P* \< 0.001 comparison of sensitized group with control group, +*P* \< 0.05 comparison of sensitized animals treated by 200 mg/kg of the extract with non-treated sensitized group. The two ANOVA followed by Tukey *post hoc* test. The criterion for the statistical significance was *P* \< 0.05](JPBS-6-97-g003){#F3}

![Comparison of the number of rearing in the open-field test. Data are expressed as mean ± standard error of the mean (*n* = 10 in each group). The two ANOVA followed by Tukey *post hoc* test. The criterion for the statistical significance was *P* \< 0.05](JPBS-6-97-g004){#F4}

Discussion {#sec1-3}
==========

The results of the present study showed that sensitizing of the animals by ovalbumin induces a depression-like behavior in rats. This animal\'s model is well-known as an experimental model of asthma.\[[@ref12][@ref35][@ref36]\] The main pathological feature of asthma is airway inflammation, which is accompanied with increasing in the airway responsiveness.\[[@ref46]\] It has also been shown that the increased serum concentrations of IgE and IgG1 is accompanied with airway inflammation and asthma.\[[@ref47]\] It has been previously shown that the secretion of cytokines such as IL-4, IL-5, IL-13 levels were increased in ovalbumin sensitized animals.\[[@ref48]\] On the other hand we have previously showed that injection of lipopolysacharide was resulted in depression like behavior in rats.\[[@ref41]\] Lipopolysaccharide is a fragment from the cell wall of Gram-negative bacteria\[[@ref49]\] which triggers the production of the cytokines.\[[@ref50][@ref51]\] Both systemic and central administrations of LPS increase the levels of the related pro-inflammatory cytokines in several areas of the brain including the hippocampus, hypothalamus and diencephalon structures.\[[@ref52][@ref53]\] A large number of evidence has confirmed the role of inflammation in depression. For example treatment with IL-2 or IFN-γ in patients with cancer, leads to high depression rates.\[[@ref54][@ref55]\] In the present study, the corresponding depressive symptoms were observed in ovalbumin sensitizes rats.\[[@ref56][@ref57]\] The results of the present study showed that immobility times in the sensitized group were higher than those of the control group in the FST. The results also showed that the crossing number in the central area of the open field by the animals of the sensitized group was lower than that of the control group. It is suggested that various anti-inflammatory manipulations have antidepressant effects in experimental animals and humans. For example, genetic knockout of IL-6 in mice reduces depressive-like behavior in the forced swim, tail suspension, learned helplessness and sucrose preference tests.\[[@ref58]\] Knockout of the IL-1 receptor and administration of IL-1 receptor antagonist also blocked stress-induced depressive-like behavior in the sucrose preference, social exploration tests, escape deficits, anhedonia and reduces social behavior.\[[@ref59][@ref60][@ref61][@ref62]\] Consistent with the pathophysiology of depression, the cytokine-induced behavioral changes are associated with alterations in the metabolism of serotonin, norepinephrine and dopamine in the brain regions which are essential for the regulation of emotion, including the limbic system (amygdala, hippocampus and nucleus accumbens), as well as the regulation of psychomotor function and reward, including the basal ganglia.\[[@ref63][@ref64]\] On the other hand, the reduced number of crossings which was observed in the open field could be related to the sickness behavior which is also repeatedly reported in rodents during neuroinflammation.\[[@ref65][@ref66]\] Furthermore, the decreased the number of entries into the central zone has been considered as an anxiety-like behavior\[[@ref67]\] therefore, it may also be suggested from the results of the present study due to sensitization.

The correlation between asthma and depression has also been suggested. Clinical reports indicate that patients with asthma commonly have also the symptoms of depression.\[[@ref68]\] It has been shown that among the asthma patients, there is a large number of those who have symptoms of anxiety and depression.\[[@ref69]\] The results of another study also showed that approximately 43% of 230 asthmatic patients had the symptoms of depression.\[[@ref68]\] A study by Lv *et al*. also found a significant difference in depression among patients with a history of asthma compared with patients who did not have such a history.\[[@ref70]\] The patients with depression were also found to exhibit all the cardinal features of inflammation.\[[@ref54]\]

The inhibition of allergic lung inflammation and airway responsiveness by the precursor of serotonin, 5-hydroxytryptophan, is a good evidence for the relationship between asthma and depression.\[[@ref71]\] 5-hydroxytryptophan also reduced the leukocyte recruitment and allergic inflammation.\[[@ref71]\]

The extracts of *V. officinalis L*. has been proposed as a natural remedy for a number of illnesses due to its pharmacological properties such as anxiolytic, antidepressant, hypnotic, mitogenic, cytoprotective and hypotensive.\[[@ref33][@ref34][@ref72][@ref73][@ref74]\] It has been reported that an aqueous extract of valerian root improved sleep quality in human without any side effect.\[[@ref75]\] Antidepressant activity of sesquiterpenes which were fractioned from the roots of Valeriana fauriei Briq the other genus of *Valerianaceae* has also been reported.\[[@ref29][@ref75]\]

Many potential mechanisms for the pharmacological action of *V. officinalis L*. have been proposed based on their agonistic effects through GABA, adenosine, barbiturate and benzodiazepine receptors.\[[@ref76][@ref77][@ref78][@ref79]\] It has been sown that valerian increases the serotonin concentrations in the brain.\[[@ref80]\] In the present study, the exact mechanism(s) or the component(s) responsible for the anti-depression like behavior wasn\'t evaluated. Valeric acid as an important component of *V. officinalis L*., has been shown to inhibit the breakdown of GABA in the central nervous system.\[[@ref81]\] Furthermore, the pharmacological properties of some components of *V. officinalis L*. are believed to be due to their antioxidant activities.\[[@ref82]\] The alcoholic extracts of valerian root have been shown to have a good effect against lipid peroxidation.\[[@ref74]\] On the other hand, it has been shown that oxidative stress has a role in depression and anxiety\[[@ref83]\] which it also increases in asthmatic patients as well in ovalbumin sensitized animals.\[[@ref84][@ref85]\] Therefore, it might be suggested as a possible mechanism in the present study. An interaction between valerian and NMDA receptors has been suggested\[[@ref24]\] and it should not be ignored as another possible mechanism.

Valerian contains over 150 chemical compounds with physiological activity including: Cadmium, cobalt, chromium, copper, iron, lithium, lipid compounds, nitrogen-containing compounds, amino acids, phenolic and terpenoids compounds.\[[@ref86]\] Each of these components may probably have a role in the anti-depression like behavior which was seen in the present study. The analgesics and sedative effects of the plant have been attributed to valeric acid however, it is chemically unstable and quickly decomposes.\[[@ref81]\] Alkaloids found in this plant are found only in small quantities.\[[@ref87]\] These alkaloids have a cholinesterase activity which may have a role in the anti-depressive like effects of the extract in the present study. However, it needs more studies to be done using other animal models of depression to confirm the beneficial effects of the plant on depression. Furthermore, further studies are recommended to characterize the component(s) and the mechanism(s) responsible for anti-depression effects of the extract in the future.

Conclusion {#sec1-4}
==========

The results of the present study showed that the hydro-alcoholic extract of *V. officinalis L*. prevented depression like behavior in ovalbumin sensitized rats. These results support the traditional belief on about the beneficial effect of *V. officinalis L*. on the nervous system. Further studies are required for determining (confirming) the protective effect of *V. officinalis L*.
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